Guggenheim Capital LLC Acelrx Pharmaceuticals Inc Transaction History
Guggenheim Capital LLC
- $13.9 Billion
- Q2 2024
Shares
4 transactions
About ACELRX PHARMACEUTICALS INC
- Ticker ACRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 7,366,600
- Market Cap $8.32M
- Description
- AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...